Ninety One UK Ltd cut its stake in shares of Dolby Laboratories (NYSE:DLB – Free Report) by 2.7% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 410,738 shares of the electronics maker’s stock after selling 11,467 shares during the period. Ninety One UK Ltd owned approximately 0.43% of Dolby Laboratories worth $29,725,000 at the end of the most recent reporting period.
A number of other hedge funds also recently made changes to their positions in DLB. MAI Capital Management boosted its stake in shares of Dolby Laboratories by 87.1% in the first quarter. MAI Capital Management now owns 348 shares of the electronics maker’s stock valued at $28,000 after purchasing an additional 162 shares during the period. Allworth Financial LP lifted its holdings in Dolby Laboratories by 590.4% in the 2nd quarter. Allworth Financial LP now owns 504 shares of the electronics maker’s stock worth $37,000 after buying an additional 431 shares in the last quarter. Mather Group LLC. purchased a new position in Dolby Laboratories in the 3rd quarter valued at about $38,000. Ameritas Advisory Services LLC purchased a new position in Dolby Laboratories in the 2nd quarter valued at about $48,000. Finally, Atlantic Union Bankshares Corp acquired a new stake in shares of Dolby Laboratories during the second quarter valued at about $50,000. Hedge funds and other institutional investors own 58.56% of the company’s stock.
Insider Buying and Selling
In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 6,751 shares of the firm’s stock in a transaction on Wednesday, December 17th. The stock was sold at an average price of $67.24, for a total value of $453,937.24. Following the sale, the chief executive officer directly owned 98,377 shares in the company, valued at approximately $6,614,869.48. This trade represents a 6.42% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Shriram Revankar sold 3,000 shares of the business’s stock in a transaction on Friday, November 21st. The shares were sold at an average price of $65.55, for a total transaction of $196,650.00. Following the transaction, the senior vice president directly owned 67,435 shares of the company’s stock, valued at approximately $4,420,364.25. This trade represents a 4.26% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 162,120 shares of company stock worth $10,906,559. Company insiders own 37.93% of the company’s stock.
Analyst Ratings Changes
Read Our Latest Stock Report on Dolby Laboratories
Dolby Laboratories Price Performance
DLB stock opened at $64.22 on Friday. The firm has a market cap of $6.13 billion, a price-to-earnings ratio of 24.42 and a beta of 0.89. Dolby Laboratories has a 1-year low of $64.02 and a 1-year high of $89.66. The firm has a fifty day moving average price of $66.23 and a two-hundred day moving average price of $70.56.
Dolby Laboratories (NYSE:DLB – Get Free Report) last posted its quarterly earnings results on Tuesday, November 18th. The electronics maker reported $0.99 EPS for the quarter, beating the consensus estimate of $0.70 by $0.29. Dolby Laboratories had a net margin of 18.90% and a return on equity of 11.99%. The business had revenue of $307.02 million during the quarter, compared to analyst estimates of $305.76 million. The company’s quarterly revenue was up .7% on a year-over-year basis. During the same period in the previous year, the business posted $0.61 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. As a group, analysts expect that Dolby Laboratories will post 2.94 EPS for the current fiscal year.
Dolby Laboratories Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Wednesday, December 10th. Investors of record on Tuesday, December 2nd were issued a $0.36 dividend. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.33. The ex-dividend date of this dividend was Tuesday, December 2nd. This represents a $1.44 annualized dividend and a dividend yield of 2.2%. Dolby Laboratories’s dividend payout ratio (DPR) is 54.75%.
Dolby Laboratories Profile
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Further Reading
- Five stocks we like better than Dolby Laboratories
- GOLD ALERT
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- Do not delete, read immediately
- Buy this $2 Gold Stock Before January 1, 2026
- Jeff Brown’s Prediction: Banks Replacing Dollars Soon
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
